Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 36.2 USD -4.16% Market Closed
Market Cap: 2B USD
Have any thoughts about
Supernus Pharmaceuticals Inc?
Write Note

Supernus Pharmaceuticals Inc
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Supernus Pharmaceuticals Inc
Other Operating Expenses Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Other Operating Expenses
-$13.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Other Operating Expenses
$2.2B
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
27%
Bristol-Myers Squibb Co
NYSE:BMY
Other Operating Expenses
$2B
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Other Operating Expenses
$1.1B
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
-2%
Merck & Co Inc
NYSE:MRK
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eli Lilly and Co
NYSE:LLY
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Supernus Pharmaceuticals Inc's Other Operating Expenses?
Other Operating Expenses
-13.5m USD

Based on the financial report for Sep 30, 2024, Supernus Pharmaceuticals Inc's Other Operating Expenses amounts to -13.5m USD.

Back to Top